|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
11228123 |
| 005 |
20210426224154.9 |
| 006 |
m o d |
| 007 |
cr un||||a|a|| |
| 008 |
100826s2002 caua ob 001 0 eng d |
| 016 |
7 |
|
|a 2001095847
|2 Uk
|
| 019 |
|
|
|a 171133236
|a 226986316
|a 259486949
|a 606587371
|a 648314527
|a 1110271452
|a 1162284208
|a 1241928797
|
| 020 |
|
|
|a 9780080549026
|q (electronic bk.)
|
| 020 |
|
|
|a 0080549020
|q (electronic bk.)
|
| 020 |
|
|
|z 0124762492
|q (alk. paper)
|
| 020 |
|
|
|z 9780124762497
|q (alk. paper)
|
| 020 |
|
|
|a 1281119237
|
| 020 |
|
|
|a 9781281119230
|
| 020 |
|
|
|a 9786611119232
|
| 020 |
|
|
|a 661111923X
|
| 035 |
|
|
|a (OCoLC)658232317
|z (OCoLC)171133236
|z (OCoLC)226986316
|z (OCoLC)259486949
|z (OCoLC)606587371
|z (OCoLC)648314527
|z (OCoLC)1110271452
|z (OCoLC)1162284208
|z (OCoLC)1241928797
|
| 035 |
|
9 |
|a (OCLCCM-CC)658232317
|
| 037 |
|
|
|a Title purchased via Dawsonera PDA
|
| 040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d N$T
|d YDXCP
|d UX0
|d IDEBK
|d E7B
|d OCLCQ
|d OCLCF
|d OCLCQ
|d OCLCO
|d NLGGC
|d NHM
|d OCLCQ
|d TOA
|d VTS
|d STF
|d BWN
|d OCLCO
|d OCLCQ
|d K6U
|d OCLCO
|d OCLCA
|d VLY
|d AJS
|
| 042 |
|
|
|a dlr
|
| 049 |
|
|
|a MAIN
|
| 050 |
|
4 |
|a RC268.43
|b .T855 2002
|
| 060 |
|
4 |
|a 2002 A-356
|
| 060 |
|
4 |
|a QZ 266
|b T9264 2002
|
| 072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
| 245 |
0 |
0 |
|a Tumor-suppressing viruses, genes, and drugs :
|b innovative cancer therapy approaches /
|c edited by Hiroshi Maruta.
|
| 260 |
|
|
|a San Diego :
|b Academic Press,
|c ©2002.
|
| 300 |
|
|
|a 1 online resource (xv, 425 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Ch. 1. Oncolytic viruses: virotherapy for cancer -- Ch. 2. Reovirus therapy of Ras-associated cancers -- Ch. 3. Oncolytic herpes simplex virus (G207) therapy: from basic to clinical -- Ch. 4. p53 and its targets -- Ch. 5. Prospects for tumor suppressor gene therapy: RB as an example -- Ch. 6. CDK inhibitors: genes and drugs -- Ch. 7. CDK inhibitors: small molecular weight compounds -- Ch. 8. NF1 and other RAS-binding peptides -- Ch. 9. Cytoskeletal tumor suppressor genes -- Ch. 10. TGF-[beta] signaling and carcinogenesis -- Ch. 11. DAN gene -- Ch. 12. Design of hammerhead ribozymes and allosterically controllable maxizymes for cancer gene therapy -- Ch. 13. Inhibitors of angiogenesis -- Ch. 14. Geranylgeranylated RhoB mediates the apoptotic and antineoplastic effects of farnesyltransferase inhibitors: new insights into cancer cell suicide -- Ch. 15. RAS binding compounds -- Ch. 16. Actin-binding drugs: MKT-007 and chaetoglobosin K (CK) -- Ch. 17. Tyr kinase inhibitors as potential anticancer agents: EGF receptor and ABL kinases -- Ch. 18. Antagonists of Rho family GTPases: blocking PAKs, ACKs, and rock -- Ch. 19. Integrin antagonists as cancer therapeutics -- Ch. 20. Functional rescue of mutant p53 as a strategy to combat cancer.
|
| 588 |
0 |
|
|a Print version record.
|
| 506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
| 533 |
|
|
|a Electronic reproduction.
|b [S.l.] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
| 538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
| 583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
| 520 |
|
|
|a Tumor Suppressing Viruses, Genes, and Drugs profiles the new generation of cancer treatments now in development. The book examines the innovative new approaches of viral, gene, and signal therapies that promise to replace or enhance conventional methods such as surgery, radiation, and chemotherapy. The timely information presented by this book should be of interest to anyone concerned with advancing cancer treatment beyond current medical practices.
|
| 546 |
|
|
|a English.
|
| 650 |
|
0 |
|a Antioncogenes.
|0 http://id.loc.gov/authorities/subjects/sh90002154
|
| 650 |
|
0 |
|a Cancer
|x Gene therapy.
|0 http://id.loc.gov/authorities/subjects/sh92005201
|
| 650 |
|
0 |
|a Viruses
|x Therapeutic use.
|
| 650 |
|
0 |
|a Cancer
|x Treatment
|x Technological innovations.
|0 http://id.loc.gov/authorities/subjects/sh88000329
|
| 650 |
|
0 |
|a Cancer
|x Molecular aspects.
|0 http://id.loc.gov/authorities/subjects/sh89006610
|
| 650 |
|
2 |
|a Neoplasms
|x therapy.
|
| 650 |
|
2 |
|a Antineoplastic Agents
|x therapeutic use.
|
| 650 |
|
2 |
|a Genetic Therapy.
|
| 650 |
|
2 |
|a Genes, Tumor Suppressor.
|
| 650 |
|
2 |
|a Neoplasms
|x genetics.
|
| 650 |
|
2 |
|a Neoplasms
|x virology.
|
| 650 |
|
6 |
|a Antioncogènes.
|
| 650 |
|
6 |
|a Cancer
|x Thérapie génique.
|
| 650 |
|
6 |
|a Virus
|x Emploi en thérapeutique.
|
| 650 |
|
6 |
|a Cancer
|x Traitement
|x Innovations.
|
| 650 |
|
6 |
|a Cancer
|x Aspect moléculaire.
|
| 650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
| 650 |
|
7 |
|a Antioncogenes.
|2 fast
|0 (OCoLC)fst00810640
|
| 650 |
|
7 |
|a Cancer
|x Gene therapy.
|2 fast
|0 (OCoLC)fst00845367
|
| 650 |
|
7 |
|a Cancer
|x Molecular aspects.
|2 fast
|0 (OCoLC)fst00845397
|
| 650 |
|
7 |
|a Cancer
|x Treatment
|x Technological innovations.
|2 fast
|0 (OCoLC)fst00845556
|
| 650 |
|
7 |
|a Viruses
|x Therapeutic use.
|2 fast
|0 (OCoLC)fst01167787
|
| 650 |
|
7 |
|a Tumeurs
|x thérapie.
|2 fmesh
|
| 650 |
|
7 |
|a Gentherapie
|2 gnd
|
| 650 |
|
7 |
|a Tumorhemmung
|2 gnd
|0 http://d-nb.info/gnd/4292868-0
|
| 650 |
|
7 |
|a Krebs
|g Medizin
|2 gnd
|0 http://d-nb.info/gnd/4073781-0
|
| 650 |
|
7 |
|a Pharmakotherapie
|2 gnd
|0 http://d-nb.info/gnd/4076066-2
|
| 650 |
|
7 |
|a Cancer
|x Chimiothérapie.
|2 ram
|
| 650 |
|
7 |
|a Cancer
|x Thérapie génique.
|2 ram
|
| 650 |
|
7 |
|a Virus
|x Emploi en thérapeutique.
|2 ram
|
| 650 |
0 |
7 |
|a Gentherapie.
|2 swd
|
| 650 |
0 |
7 |
|a Tumorhemmung.
|2 swd
|
| 650 |
0 |
7 |
|a Krebs <Medizin>.
|2 swd
|
| 650 |
0 |
7 |
|a Pharmakotherapie.
|2 swd
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Maruta, Hiroshi.
|0 http://id.loc.gov/authorities/names/n96076819
|
| 776 |
0 |
8 |
|i Print version:
|t Tumor-suppressing viruses, genes, and drugs.
|d San Diego : Academic Press, ©2002
|w (DLC) 2001095847
|w (OCoLC)48466968
|
| 776 |
0 |
8 |
|i Print version:
|t Tumor-suppressing viruses, genes, and drugs.
|d San Diego : Academic Press, ©2002
|z 9780124762497
|w (DLC) 2001095847
|w (OCoLC)48466968
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|i 07a4b3fa-7c34-50a4-9b7c-c6f051475bd1
|s a3c96ff3-e3a1-5c5f-882b-9acb6f034be8
|
| 928 |
|
|
|t Library of Congress classification
|a RC268.43 .T855 2002
|l Online
|c UC-FullText
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=203344
|z eBooks on EBSCOhost
|g ebooks
|i 12292207
|
